Given the widespread expression and multiple downstream functions of IL-33 as well as the difficulty in identifying pancreatic cancer initiation clinically, IL-33 may not be a direct target for the prevention or early diagnosis of pancreatic cancer. The gene discussed is IL33; the disease is pancreatic neoplasm.